Acromegaly affects your body’s bones and tissues and causes them to grow in irregular ways. Octreotide is a peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors. Octreotide lowers many substances in the body such as insulin and glucagon (involved in regulating blood sugar), growth hormone, and chemicals that affect digestion
Recalcitrant Hypocalcemia: Post-Surgical Hypoparathyroidism Exacerbated by a Chyle Leak Treated
Octreotide is used to treat acromegaly.
What is octreotide, and what is it used for
Octreotide is a medication used in the treatment of acromegaly, a disorder associated with excessive blood levels of growth hormone, and severe, watery diarrhea caused by certain types of gastrointestinal (gi) tumors. Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or vipomas) or metastatic carcinoid tumors (tumors that has already spread in the body). Octreotide, sold under the brand name sandostatin among others, is an octa peptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. This activity describes the indications, action, and contraindications for octreotide as a valuable agent in the management of acromegaly and thyrotrophinomas, as well as carcinoid syndrome.
Octreotide is used to treat acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features And other symptoms) in people who have been treated successfully with octreotide injection or lanreotide injection. Find patient medical information for octreotide (sandostatin, bynfezia) on webmd including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
